Your browser doesn't support javascript.
loading
Validation of a Bayesian learning model to predict the risk for cannabis use disorder.
Ruberu, Thanthirige Lakshika M; Rajapaksha, Rajapaksha Mudalige Dhanushka S; Heitzeg, Mary M; Klaus, Ryan; Boden, Joseph M; Biswas, Swati; Choudhary, Pankaj.
Afiliação
  • Ruberu TLM; Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX 75080, United States.
  • Rajapaksha RMDS; Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX 75080, United States.
  • Heitzeg MM; Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109, United States.
  • Klaus R; Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109, United States.
  • Boden JM; Department of Psychological Medicine, University of Otago, Christchurch 8011, New Zealand.
  • Biswas S; Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX 75080, United States.
  • Choudhary P; Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX 75080, United States.
Addict Behav ; 146: 107799, 2023 11.
Article em En | MEDLINE | ID: mdl-37451153
ABSTRACT

BACKGROUND:

Cannabis use disorder (CUD) is a growing public health problem. Early identification of adolescents and young adults at risk of developing CUD in the future may help stem this trend. A logistic regression model fitted using a Bayesian learning approach was developed recently to predict the risk of future CUD based on seven risk factors in adolescence and youth. A nationally representative longitudinal dataset, Add Health was used to train the model (henceforth referred as Add Health model).

METHODS:

We validated the Add Health model on two cohorts, namely, Michigan Longitudinal Study (MLS) and Christchurch Health and Development Study (CHDS) using longitudinal data from participants until they were approximately 30 years old (to be consistent with the training data from Add Health). If a participant was diagnosed with CUD at any age during this period, they were considered a case. We calculated the area under the curve (AUC) and the ratio of expected and observed number of cases (E/O). We also explored recalibrating the model to account for differences in population prevalence.

RESULTS:

The cohort sizes used for validation were 424 (53 cases) for MLS and 637 (105 cases) for CHDS. AUCs for the two cohorts were 0.66 (MLS) and 0.73 (CHDS) and the corresponding E/O ratios (after recalibration) were 0.995 and 0.999.

CONCLUSION:

The external validation of the Add Health model on two different cohorts lends confidence to the model's ability to identify adolescent or young adult cannabis users at high risk of developing CUD in later life.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Cannabis / Abuso de Maconha / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: Addict Behav Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Cannabis / Abuso de Maconha / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: Addict Behav Ano de publicação: 2023 Tipo de documento: Article